Small Cap Feast
Small Cap Feast – 26th January 2017
Dish of the Day:
No AIM Joiners Today
No AIM Joiners Today
Off the Menu:
No AIM Leavers Today
No AIM Leavers Today
What’s Cooking in the IPO Kitchen?
Rainbow Rare Earths has published a prospectus. It has raised $8m to fast-track fully permitted high grade Gakara ‘rare earths’ project to production in Burundi. Intends to join the Standard List of the LSE.
Impact healthcare REIT— Intends to float on the main market. Seeks to raise £160m to acquire a portfolio of up to 58 care homes. Expected Admission 7 March.
Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January.
Mobile Streams (MOS.L) 4.13p £3.78m
HY Dec 16 trading update from the independent mobile content store. Subscriber numbers in India exceeded 100,000 active subscribers and have since risen to over 130,000 during January 2017. Successful fundraising of £2.2m (before expenses) to fund growth in India. £2.8m of cash and cash equivalents at year end. Trading during the first half of the financial year was in line with expectations and unaudited revenues were approximately £3.6m (H1 2015: £8.0m). All revenue is from continuing operations. Argentina remains challenging. Focus is moving to India.
EU Supply (EUSP.L) 12.25p £8.3m
FYDec16 Trading update from e-procurement software provider. Results expected to be slightly ahead of market expectations. Revenue is expected to be up 21% to £3.4m (2015: £2.8m), of which, as at 31 December 2016, approximately 71% (2015: 73%) was expected to be of recurring or repeated nature. Loss before interest and tax is expected to be reduced by approximately 43% to £0.8m (2015: £1.4m), despite the negative impact of foreign exchange movements. Revenue growth has continued in Q4 2016 and the Group is expected to have been profitable before tax in the quarter.
Zoo Digital Group (ZOO.L) 8.75p £2.86m
FYMar17 trading update from the provider of subtitling and digital distribution services for the global entertainment industry. Momentum seen in the first half of the financial year has continued and, as such, ZOO expects the second half performance to show less seasonal variation than in previous years in terms of both revenue and EBITDA, with reported EBITDA for the full year expected to be at least $1.8m. This, in turn, means that the Company expects to deliver a significant improvement for the full year when compared to the financial year ended 31 March 2016.
Brooks Macdonald (BRK.L) 2012.5p £276.12m
Funds under management update and HY Dec 2016 trading update from the integrated investment management group. Over the last six months discretionary funds under management have risen by 12.4% ending the period at £9.33 billion. Brexit and Trump have affected sentiment “over the last six months and whilst portfolios have performed well in these challenging conditions, we expect market volatility to remain.” FYJun17E PE of 18.6x and 2.1% yield.
EMIS Group (EMIS.L) 915.5p £575.5m
HYDec16 trading update from the UK specialist in connected healthcare software and services. Trading in the second half of the year was consistent with the market conditions experienced in the first half and overall performance for the year was in line with the Board’s expectations. NHS funding pressures have been unhelpful but digital transformation an important part of the long term NHS plan. At the same time, the Group continues to benefit from its strong revenue visibility, market shares, solid order book and pipeline. FY16E rev of £160.34m an d £38.75m PBT.
Frontier Smart Technology (FST.L) 78.5p £31.73m
FYDec16 trading update from the pioneer in technologies for Digital Radio and Smart Audio devices. The Group expects to report an improved financial performance for FY 2016, achieving a positive Group EBITDA on a continuing basis, ahead of current market expectations. Revenue for the financial year is expected to be approximately £32m and underlying EBITDA is anticipated to be c. £0.7m. Solid cash position of £3.4m. This is due to improved Digital Radio revenue generation, a decrease in R&D expenditure, the sale of the loss-making Healthcare division and foreign exchange tailwinds. The Board expects revenue and underlying EBITDA to improve in 2017, driven by growth in Smart Audio.
Keras Resources (KRS.L) 0.45p £6.97m
The Australian gold mining company, has raised £600k at a placing price of 0.35p per Ordinary Share. Proceeds of the Placing will support ongoing exploration and development works at the Company’s 100% owned, flagship Klondyke Gold Project in the East Pilbara District of Western Australia, which has a current resource estimate of 5.6Mt at 2.08g/t Au for 374k oz with significant further upside potential indicated. Funds will also be used to retire 12-month loan notes secured in February 2016 and for general working capital purposes as the Company continues to finalise plans for a potential listing on the ASX.
Ebiquity (EBQ.L) 102.5p £79.13m
FY Dec 16 pre-close from the independent marketing analytics specialists. Ebiquity has continued to grow revenue with an increase in total unaudited revenues of 9%. Group margins are broadly in line with those achieved in 2015, with anticipated mid-single digit growth in operating profit and earnings. Ebiquity continued to benefit from the weakness of sterling, particularly in the second half of the year, with two-thirds of revenue denominated in non-sterling currency. FX revenue gains across the year amounted to £4.5m. The start to 2017 has seen a noticeable pick up in new business activity. FY16E PE of 9.3x.
Frenkel Topping Group (FEN.L) 52.5p £40.4m
FYDec16 trading update from specialist independent financial advisor and asset manager focussed on asset protection for vulnerable clients. Profit from operations is expected to be in line with market expectations of £1.5m (2015: £1.5m) with cash generated from operations of £1.6m (2015: £0.9m). AUM across the Company had grown to £745m as at 31 Dec 2016 (2015: £666m) and following the launch of Frenkel Topping Investment Management Limited (FTIM) in May 2016, the Company is pleased to report Assets under Administration (AUM) on a discretionary mandate with FTIM amounted to £253m as at 31 Dec 16 with further growth anticipated over the first half of 2017.
Ceres Power Holding (CWR.L) 8.1p £81.65m
H1 Dec 16 trading statement from the specialist in low cost, next generation steel fuel cell technology. Two new development agreements signed, bringing total to four including with Honda, Nissan and Cummins; well on track to meet target of five by the end of 2017. Good progress on product development and geographical expansion. £1.5 million in revenue and other operating income for the first half, a threefold increase compared to first half last year. £4.8m order book and three new evaluation agreements underway signed with potential future partners.
Emily Liu, CFA, CAIA
0203 764 2344
0203 764 2345
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.